VG
Vns Gopal Raju Kurapati
About Vns Gopal Raju Kurapati
Data last updated:
Vns Gopal Raju Kurapati is a Director at Averx Drugs Private Limited (since 2014). The company operates in Pharma. Averx Drugs Private Limited reported revenue of ₹6.36 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Averx Drugs Private Limited U24100AP2014PTC095163 | Director | 26 Aug 2014 | 2014 | ₹6.36 Cr (FY 2021) | Active |
Board colleagues of Vns Gopal Raju Kurapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhana Lakshmi Tirupathi | 07167886 | Averx Drugs Private Limited | Director |
| Nagasekhar Ramineni | 08400770 | Averx Drugs Private Limited | Managing Director |
| Srinivas Ramineni | 02061777 | Averx Drugs Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vns Gopal Raju Kurapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vns Gopal Raju Kurapati
Vns Gopal Raju Kurapati currently holds 1 directorship: Averx Drugs Private Limited (Director, since 26 Aug 2014, revenue ₹6.36 Cr (FY 2021)).
Vns Gopal Raju Kurapati was first appointed on 26 Aug 2014 as Director at Averx Drugs Private Limited.
The current boards of Vns Gopal Raju Kurapati's companies include Dhana Lakshmi Tirupathi (Averx Drugs Private Limited), Nagasekhar Ramineni (Averx Drugs Private Limited), Srinivas Ramineni (Averx Drugs Private Limited).